학술논문

Durable Response to Enfortumab Vedotin Compared to Re-challenging Chemotherapy in Metastatic Urothelial Carcinoma After Checkpoint Inhibitors
Document Type
Article
Source
In: Targeted Oncology. (Targeted Oncology, May 2024, 19(3):401-410)
Subject
Language
English
ISSN
1776260X
17762596